Respiratory
Leukotriene receptor antagonists
Tablets that block the cysteinyl leukotriene receptor, reducing bronchoconstriction and airway inflammation; an add-on controller in asthma, useful in aspirin-exacerbated and exercise-induced asthma.
آلية العمل
- 5-Lipoxygenase converts arachidonic acid into the cysteinyl leukotrienes (LTC4, LTD4, LTE4), released by mast cells and eosinophils.
- Acting on CysLT1 receptors, they contract bronchial smooth muscle, increase mucus and vascular leak, and attract eosinophils.
- Montelukast and zafirlukast block CysLT1 receptors; zileuton instead inhibits 5-lipoxygenase.
الأهداف الجزيئية
- Cysteinyl leukotriene receptor 1 (CysLT1): Antagonist (montelukast, zafirlukast)
- 5-Lipoxygenase: Inhibitor (zileuton)
أدوية Leukotriene receptor antagonists
Leukotriene receptor antagonists
- Montelukast (Once daily by mouth.)
- Zafirlukast
5-Lipoxygenase inhibitor
- Zileuton (5-lipoxygenase inhibitor; monitor liver function.)
الاستخدامات العلاجية
- Persistent asthma, as an add-on or alternative controller to an inhaled corticosteroid
- Exercise-induced bronchospasm
- Aspirin-exacerbated respiratory disease
- Allergic rhinitis
الأمراض التي يعالجها
الآثار الجانبية
- Headache and gastrointestinal upset
- Neuropsychiatric effects with montelukast: agitation, sleep disturbance, depression and suicidal thoughts
- Raised liver enzymes (zileuton, zafirlukast)
موانع الاستعمال حسب الحالة
- Depression or other psychiatric illness (montelukast) (بحذر): Montelukast can cause mood changes and suicidal thoughts.
- Liver cirrhosis (بحذر): Zileuton can damage the liver.
محاذير وتداخلات أخرى
- They are not bronchodilators for an acute attack.
موضوعات مرتبطة
مكتوب من
- Lippincott Illustrated Reviews: Pharmacology, 7th ed., Ch. 39, Drugs for Disorders of the Respiratory System, Leukotriene modifiers
- Basic & Clinical Pharmacology (Katzung), 14th ed., Ch. 20, Drugs Used in Asthma, Leukotriene pathway inhibitors
مرجع تعليمي، وليس استشارة طبية أو تشخيصاً أو علاجاً.